EN
中
Home
Our Company
Our Story
Global Footprint
Our Leadership
Our Impact
Science
Platform
Disease Areas
Pipeline
Mechanism of Action
Media
Press Releases
Contact Us
Our Offices
General Enquiries
Media Contact
Investor Contact
Career
Ethics and Compliance
Our Investors
Series A closed in January 2018 from high quality investors including:
Advantech Capital
Efung Capital
3E Bioventures Capital
SDIC Venture Capital
CASH Capital
Founder H Fund
Sangel Capital
Cowin Capital Group
Sihuan
Ping An Ventures
Korea Investment Partners
Bay City Capital
Elite Capital
GF XINDE